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 Identifying disease specific distress in Inflammatory Bowel Disease 
(IBD distress) 
Abstract:  
Objectives 
Inflammatory bowel disease (IBD) imposes a significant burden on patients. We have noticed an 
underlying presence of distress, seemingly distinct from anxiety and depression, in qualitative data 
collected for previous studies. Disease-related distress has been explored in diabetes, but has not 
been addressed in IBD. We aimed to determine the presence of IBD distress to inform development 
of a scale for assessing the phenomenon.   
Methods 
This three-phase study used (1) a conceptual framework based on diabetes-distress to conduct 
secondary analysis of qualitative data from four previous IBD studies (n= 49 transcripts). Patient 
advisors confirmed the themes identified as causing distress, which guided (2) a focus group with 
people with IBD (n=8) and (3) Items generated from phase 1 and 2 were subsequently used for a 
modified Delphi survey of IBD health professionals.   
Results 
Five IBD-distress themes were identified: Emotional distress; Healthcare-related distress; 
Interpersonal/Social distress; Treatment-related distress; and Symptom-related distress. 
Discussion 
Disease-specific distress in IBD was identified and is distinct from stress, anxiety and depression. 
Some causes of IBD distress overlap with diabetes-distress, but existing diabetes-distress scales do 
not explain all the distress experienced by people with IBD and development of a new IBD-distress 
scale is warranted. 
Key words: 
Inflammatory Bowel Disease, Distress, Crohn’s Disease, Ulcerative Colitis, IBD distress 
Introduction 
Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition with unknown aetiology and 
variable and unpredictable relapsing-remitting pattern1.  Of its two predominant conditions, ulcerative 
colitis (UC) involves only the colon and rectum, while Crohn’s disease (CD) may affect any part of the 
gastrointestinal tract. Unclassified IBD (IBDU) cannot be classified as either UC or CD and proctitis is 
inflammation confined to the rectum.  The symptoms of IBD vary but include diarrhoea, abdominal 
pain and fatigue, extra-intestinal symptoms such as arthritis, and the risk of colorectal cancer may 
increase as a complication of IBD2.  Incidence of IBD is increasing worldwide with approximately 
1:400 adults affected in Westernised Countries3. 
 
IBD imposes a heavy psychosocial burden. Anxiety, depression and stress may be linked to 
increased risk of disease flare-ups, or to consequences of the disease, need for surgery and its 
unpredictable course4-6.  However, these issues of psychological morbidity (anxiety and depression), 
emotional coping and psychosocial stress, do not appear to reflect the whole experience of people 
with IBD. In detailed interviews with people with IBD conducted over a number of studies addressing 
continence7, fatigue8 and stigma9, and through development of a specific questionnaire for measuring 
bowel symptoms10, many participants in these studies have told us that they are not depressed or 
anxious, do not feel generally stressed and are not coping poorly. Instead, people have explained that 
they resent the impact of IBD on their children and partners, and are upset at the disease, its 
unpredictability and antisocial consequences. They feel vulnerable if not able to access urgent care 
when needed, may not be adhering to treatment that they resent, and feel overwhelmed by their 
illness, feeling that IBD controls their life7-10.  
 
The biopsychosocial impact of chronic diseases causing disease-related distress - a state distinct 
from anxiety, stress or depression and relating instead to disease-specific physical or mental anguish 
or suffering - is now recognised11. Disease-specific distress measurements and interventions have 
been developed in other long-term conditions, most notably diabetes12-13 and asthma14. Diabetes-
specific distress (DSD) is distinct from anxiety and depression15-17, is strongly associated with self-
management behaviours, treatment compliance and hence control of blood glucose18. DSD is 
characterised in four domains: symptom distress, regimen distress, health professional 
communication-associated distress, and social relationship distress13. In diabetes, two established 
scales with strong psychometric validity and reliability are available for both research and clinical 
use12,19-20. The recognition of distress in diabetes is mainstream in research and increasingly 
commonplace in clinical practice. Robust measures are available to detect DSD, leading to both 
increased professional attention and self-management support13.  
 
Distress has rarely been mentioned in relation to IBD, but where studied, researchers have usually 
measured anxiety, depression and stress4-6, rather than the disease-specific nature of distress. If in 
prevalence studies, in trials of behavioural and psychosocial interventions and in clinical practice we 
continue to think only in terms of anxiety and depression for IBD, we may be trying to identify, monitor 
and treat the wrong issue. The extent of emotional burden associated with living with IBD, the 
advances in detection and management of disease-specific distress in other long-term conditions and 
its apparent relationship to self-management behaviours and clinical outcomes makes this an 
important topic for study for people with IBD and their clinicians. 
 
Purpose: 
To detect IBD-specific distress; to compare the domains of IBD-distress to diabetes-distress to 
identify if DSD scales could be applied to an IBD population and if not, to generate items for a new 
IBD-distress scale. 
Methods 
This “proof of concept” study formed the preliminary qualitative stage of a subsequent mixed methods 
study. It employed three phases to detect IBD distress and identify the domains of disease-specific 
distress in IBD. In particular the study aimed to answer the question: What are the items of disease-
specific distress expressed by people with IBD and is a new scale required to measure IBD distress? 
Phase 1: Secondary Analysis of Existing Data 
Secondary analysis of transcripts from in-depth interviews or free-text data from four previous studies 
exploring the experiences of people with IBD and fatigue8, faecal incontinence7, and stigma9, and 
from the development of another outcome measure10 was undertaken. Following ethical approval for 
all phases of this preliminary work, 99 participants from these previous studies who had given 
permission to be contacted about future studies were approached for written consent to re-analyse 
their qualitative data to identify the concept and themes associated with IBD distress. We compared 
data from previous qualitative interviews with a conceptual framework (Table 1) based on the 
domains of DSD from two validated measures19-20. Data were coded independently by two members 
of the team (SW, LD) and verified by patient representatives (AB, SK), who reviewed, debated and 
reached a consensus on codes and themes against the conceptual framework whilst also identifying 
possible new domains specific to people with IBD. The pragmatic thematic analysis method of 
Fereday & Muir-Cochrane21 was followed. This approach was suitable as the team had some 
expectation of what the data may reveal (in this case, analysis was guided by the domains identified 
in DSD), and it enabled new themes, complimentary to those being looked for, to emerge. 
Phase 2: Focus Group 
A focus group (n=8) was then conducted to explore the findings of the thematic analysis. Community-
based English-speaking volunteers aged over 17 years with a confirmed diagnosis of IBD (CD, UC, 
IBDU or Proctitis) recruited via local Crohn’s & Colitis UK support groups were invited to participate. A 
discussion schedule was followed and using the findings from Phase 1 and their own understanding 
of distress, participants were asked to consider which aspects of distress were specific to IBD and 
important for inclusion in a new distress scale for IBD. The focus group was audio recorded and 
professionally transcribed verbatim. Thematic analysis of the focus group interview was undertaken. 
Data were again coded independently by two members of the team (SW, LD), who discussed, 
debated and reached consensus on codes and themes with patient representatives on the study 
steering group (AB, CC, LE and SK).  
Phase 3: Modified Delphi Survey of Health Professionals 
SW, SC and LD identified a series of 51 statements (items) from phase 1 and 2 that represented all 
aspects of living with IBD that were distressing under each of the themes, and were potentially to be 
included in a new draft IBD-distress scale. Through chain referral, a convenience sample of 63 health 
professionals experienced in IBD care were asked to indicate agreement or not with the 51 items in a 
pragmatic modified Delphi survey - consensus was achieved in a single round. Consenting clinicians 
were asked to consider whether the items addressed aspects of IBD distress that they encountered in 
clinical practice, and to identify any additional items for inclusion.  
 
Results 
Data were collected between February and September 2014.  
Phase 1: Thematic analysis of secondary data 
From 99 people with IBD contacted from previous studies, 49 replied giving consent for the inclusion 
of interview data in the secondary analysis. Two people declined to participate, due to not feeling 
distressed. 
Five main distress themes emerged: Emotional distress; Healthcare-related distress; 
Interpersonal/social distress; Treatment-related distress; and Symptom-related distress. Each theme 
had several sub-themes - many were consistent with DSD whilst others were specific distressing 
factors in IBD (Table 2). Similarly, some items within the conceptual framework (Table 1) appeared to 
be specific to diabetes-distress and were not evident within the IBD data (Table 2). Verbatim quotes 
are given in italics with the participant’s gender, age, type of IBD and original interview study 
identifying them.   
Emotional Distress 
Emotional distress was commonly identified.  A range of negative emotions were associated with IBD 
and expressed within the interviews including anger, fear and low mood: 
“Some days are good, some days I get angry, sometimes I get bitter because I know that if I’d 
been taken notice of in the beginning, because I was 16 when I first went with problems “ 
Female, 38, CD9 
“But once they flare up, you know, it’s frightening, it’s absolutely frightening” 
Male, 72, UC8 
“In those days when I was having really nasty, demanding attacks of bowel opening they 
would leave me very, very drained of strength and feeling on the verge of depression almost 
sometimes” 
Male, 82, UC8 
Other negative emotions - feeling frustrated, fed-up, miserable, devastated and hopeless – were also 
expressed. Additionally, people with IBD could feel overwhelmed and burnt-out by the demands of 
living with the condition: 
“I did get to one stage where I was having to go to the toilet 23 times in 24 hours … That is 
no way to live, and the hours that were in between visits were not pleasant anyway, it’s like a 
boiling kettle in your stomach, it’s bubbling away there. And then suddenly it gets too much 
and off you go to the toilet, and quite often, I’ll be honest with you, I didn’t actually make it to 
the toilet, so it was just clean up, clean the house where you’d been and it was just absolutely 
miserable” 
Male, 72, UC8 
“I would often sleep in the car for half an hour, I would pull up in a lay-by and sleep because I 
was so, I couldn’t do it, I couldn’t keep going. I couldn’t manage the demands of the job with 
the illness, it was impossible.” 
Male, 45, CD8 
Some people were not accepting of their diagnosis, which caused emotional distress: 
“I don’t think I’ll ever change my mind about that, I’ve got it and it is disgusting” 
Male, 54, CD9 
“I hate the colitis, I hate it” 
Female, 69, UC9 
A sense that IBD controlled the lives of patients was a prevalent theme, affecting both men and 
women: 
“ The fear of accidents or of making smells and noises is a very real factor in all our lives and 
can sometimes dominate our decision making and day-to-day activities...my biggest concern 
was just being able to live again, because it really did take over my life.” 
Female, 50, UC10 
“Devastating would be the word I would use, it touches virtually all aspects … it actually 
touches all aspects of my life and I can’t live the life that I want to live because of the 
Crohn’s.” 
Male, M45, CD8 
A perception that IBD caused a drain on energy was a common finding amongst male and female 
participants. Although anticipated as one set of transcripts being analysed was from a fatigue in IBD 
study, this was also distressing in other studies: 
“It is really distressing, because I just don’t know what to do with myself, I’m that tired.” 
Male, 72, UC8 
“I have little energy, which I really dislike” 
Female, 30, UC10 
Other sub-themes evident in the transcripts that were not present in the DSD scales yet clearly 
caused emotional distress, included feeling embarrassed or disgusted by the disease/symptoms:  
 “...and I think it’s disgusting and I think it’s horrible and smelly and going to the toilet all the 
time and seeing all this gunk and blood and mucus.” 
Female, 37, UC9 
“I feel dirty all the time and wear pads all the time. I feel un-sexy and don’t have sexual 
relationships with my husband for a number of years. I feel very sad about that.” 
Female, 65, UC10 
IBD could result in a distressing change in self-esteem/self-image for some: 
“I’d like to be normal again....I can’t be the Dad I want to be, I can’t be the husband I want to 
be, I can’t be the person I want to be and that is very, very difficult.” 
Male, 45, CD8 
The uncertainty and unpredictability of living with IBD was also a source of emotional distress, relating 
to disease relapses, uncertainty over treatment options, and surgery in particular: 
“It’s like living with a time-bomb, you just never know when things are going to happen, and 
you can’t plan for anything... you never really know when you are going to get a flare up.” 
Male, 72, UC8 
Healthcare-related Distress 
The most prevalent cause of distress identified was dissatisfaction with health professionals, evident 
in data from all four studies, and relating both primary and secondary care experiences:  
“The current set-up at the hospital seems to be completely based on tick boxes. So you say 
you’re experiencing x, y, z they’ll do blood tests; if the blood tests come back normal, well you 
can’t be, you’re making it up...and I’ve had several battles with them...but basically I have 
given up with the hospital consultants... I’ve given up fighting them, because actually it takes 
more energy than it’s worth...I find that incredibly frustrating.” 
Male, 47, CD8 
“I didn’t have anyone to go to. I didn’t even go to my own doctor... My GP doesn’t understand 
what colitis is.” 
Female, 37, UC9 
This distress also related to concerns expressed by participants about not being taken seriously by 
the health professionals caring for them: 
“As far as the fatigue is concerned, I don’t really bother with, I don’t really discuss that with 
the hospital any more because they’re not interested.” 
Male, 47, CD8 
In addition, having no regular doctor was a concern for some: 
“Um, I’ve gone through a succession of changes of doctors for whatever reason. I don’t get to 
see the same doctor...that’s very frustrating.” 
Male, 56, CD9 
 
Interpersonal/social distress 
Many uncomfortable social situations that caused distress were reported, invariably related to bowel 
symptoms. People were reluctant to stay away from home, and felt that others could detect their 
bowel problem: 
“If you have an accident, you think everybody’s watching you. They’re probably not even 
thinking about you, but you’ve got this feeling that they are.” 
Male, 54, CD9 
A lack of appreciation of the difficulty of living with IBD, as well as a lack of emotional support from 
friends and family was also evident, often leading to isolation:  
  “Due to not attending functions I have lost touch with friends. I feel very isolated” 
Female, 50, CD10 
In some cases friends and family would not believe an individual was unwell: 
“My mother refuses to this day to acknowledge there is anything wrong with me, because she 
doesn’t fully understand the illness that caused it and blamed my eating habits...[she felt] that 
I was doing it on purpose” 
Female, 61, CD9 
 
Lack of support from employers was also evidenced. Although absent from the DSD scales, in IBD 
this  often related to employers not believing the individual was unwell: 
“There was no support, but I told occupational health, but there was no support... when I was 
off work [my manager] thought I was working on the side as well as being off work on the 
sick...” 
Male, 45, CD8 
Unlike with diabetes, people with IBD felt unable to talk about the disease or the impact it was having 
on them, which was also a source of distress. Participants were reluctant to discuss IBD with others, 
fearing the reaction others may have to the subject taboo of bowels:   
“I can’t stand the idea that other people would know. So you know, I have to, it’s something 
for me that’s private...To me it makes me feel like they would view me differently, they would 
in some way think less of me” 
Female, 47, CD9 
People with IBD were worried about how their disease impacted on their family, restricting their 
partner’s social activities:  
“I feel as if I spoil my husband’s social events always worried about toilets and eating.” 
Female, 53, CD7 
Participants also felt anxious or guilty about the risk of passing the illness on to their children:   
“I worry that my children might get ulcerative colitis.” 
Female, 50, UC10 
Treatment-related distress 
Distress associated with treatment was apparent in the interviews. People with IBD were concerned 
about diet, but for different reasons to those with diabetes.  
“The worst problem for me is when an event is arranged I have to think about what I eat for a 
few days before to help maintain a good level of control so that where possible I can control 
my IBD”. 
Female, 62, CD10 
Interventions for IBD, side effects of medication, or having a stoma, also caused distress: 
“..that’s the other thing, dealing with treatment and side-effects, that’s difficult too because 
that’s messed me up.” 
Male, 45, CD8 
“..but it’s just having the bag, it’s just knowing that there’s poo in it and I’m walking about with 
a bag of poo and it’s just, no although you’ve got that freedom and everything, it’s still not the 
answer to me.” 
Male, 54, CD9 
Symptom-related distress 
Symptom-related distress was a new theme, not identified in the DSD scales, largely related to bowel 
symptoms or having to cope with these symptoms. Fear of faecal incontinence (FI) was the leading 
cause of symptom-related distress:  
“The fear of it [FI] is the worst aspect of it all. I had a terrible experience two years ago in a 
minibus with seven people. I was in a terrible state.” 
Male, 56, CD9 
“It makes me feel trapped at home and especially anxious when travelling- trains, tubes, 
planes are a nightmare. The anxiety of lack of ability to find a loo when necessary adds to 
stress....I travel with spare pants, wipes and fingers crossed!” 
Female, 69, CD7 
The impact of IBD-related fatigue on cognition was also a cause of distress for some: 
“I couldn’t think clearly and sharply as I wanted to a lot of, not all the time, but a lot of the 
time.” 
Male, 45, CD8 
 
Phase 2:  Focus group findings 
Eight people with IBD (4 males, 4 females; aged 17-62, mean 37 years; two who reported CD; six 
who reported UC),  participated.  The focus group was conducted by LD and observed by SW. 
Similar issues were revealed in the focus group data. There was evidence of emotional distress for 
example in a recently-diagnosed participant disheartened by the change in lifestyle his disease had 
imposed on him. Similarly, the need to plan for every day was troublesome, as was the lack of a 
known cure:   
“If you have depression or anxiety because you are separated, or you have financial 
problem, so somehow you solve it one day.  And you know it’s a problem, what it’s about.  
But with [IBD] you know the problem doesn’t have any cure or doesn’t get solved... but you 
know the source and you know it is still there for you.  So it makes you feel worse really.” 
Malik, 56, CD  
Evidence of healthcare-related distress was less apparent than in the Phase 1 data, but Interpersonal 
and social distress was evident throughout the focus group discussion, with all participants providing 
examples of the impact of IBD on their lives and the distress this caused. On the day of the focus 
group, Toby had just learnt that his temporary stoma could not yet be reversed:  
“I’m planning on going on holiday with my friends in, end of July, August, well I was hoping 
to get an ileostomy reversal, [but] right now I don’t think I’ll go on holiday, because I just 
can’t live with being on the beach, I can’t - I won’t even take my top off to go sunbathing in 
the fear that everybody is just going to be looking at me.” 
Toby, 17, UC 
Everyone agreed that the topic of bowel disease was taboo, and the distress associated with the 
potential stigma of being ‘found out’ was reflected:  
Jenny: “Because I wonder how many [people with IBD] can actually tell people what they’ve 
actually got, because do you know what, I’ve never, I’ve never admitted it never, ever ... that 
I’ve got problems”. 
Toby: “I am at school and none of my friends know at all. I just can’t tell them ... because 
they’re just going to look at me differently.”   
Jenny: “I think it’s got such a stigma.”   
Toby: “I mean everyone says, no they won’t look at you differently, they’re your friends.  But 
the fact is, they will.  And there’s no way to get round it.” 
Annette: “Someone says it’s not the sexy subject. It’s not a sexy illness, you know, it’s not 
attractive. So it’s difficult to explain what is going on.” 
 
Jenny, 41,UC; Toby, 17, UC; Annette, 49, UC 
 
The distressing impact of IBD on social activities and on family and interpersonal relationships was 
also revealed. Malik (56, CD) explained how the illness had caused him to withdraw from many of the 
community activities he used to be involved in, making him ‘isolated from his friends,’ while Toby (17, 
UC) felt his parents did not understand his situation, including the repeated failure of his UC to 
respond to medicines. Annette offered a thoughtful description of how IBD ‘tested’ her new 
relationship:  
“I met a new partner two years ago.  It was so difficult for me to explain what’s going on.  
For some time I didn’t say anything, I just said, ‘Oh maybe, maybe later’... it was very 
difficult for me to explain, to cross this line and say that I’ve got this condition, and how I feel 
and everything.  It took me a lot of time because it was not easy to explain how it is.  I gave 
him the book about the disease and everything, the symptoms, then he just started to 
understand why.  But it was also the ‘exam’ for our relationship and he passed it!” 
Annette,  49, UC 
This difficulty might also include broaching the issue of having children or not:  
“I decided that I wasn’t going to have children, because I didn’t want to pass it 
on…..[became tearful]….. I was only concerned that my husband, when I said to him, ‘I 
don’t want to have children, I really don’t think it’s a good idea...’” 
    
Geraldine, 42, CD 
 
Some participants reported treatment-related distress; Brigitte (29, UC) commented on the distress 
associated with attending hospital for her first colonoscopy when her mother and sisters, who she 
would have preferred to accompany her, lived in another country:  
“It depends what kind of family circle you’ve got around you, that’s the thing, because for 
me, I’m on my own here….  So when I was told I had to go for the colonoscopy, that you 
can go on your own, but you can’t leave the hospital on your own because of sedation and 
stuff like that.  I was like, ‘Who am I going to get? Who am I going to ask?  ” 
Toby was distressed by the inefficacy of the many medicines that had been prescribed to try and 
control his UC:  
“Because I’ve been on every medication, I was always optimistic after starting a new one, 
then always going to the doctor and getting the bad news, and sort of just given up hope.” 
and that his temporary stoma did not resolve the problem of his illness: 
“Having an ileostomy, it’s not really solving the problem.  It’s just minimising the symptoms, 
although I’m on azathioprine as well, I just feel like I’m in just this void.”  
Toby, 17, UC 
 
Participants also talked about symptom-related distress, for example, dealing with FI:  
“I have had a huge accident in the middle of town with nothing (with me).  So what do I do? I 
just had to get on the train, my head down, and hopefully people don’t look – and then walk 
from the station back home, head down-  oh it was awful.” 
Jenny, 41, UC 
Geraldine (42, CD) was also very clear about the main cause of her distress:  
“All my distress comes from how it’s affected my life and how it’s affected my body, because 
my Crohn’s is fistulating Crohn’s.  So it fistulated into my bladder, which was disgusting. And 
I didn’t tell anyone. I hid that for years, believe it or not.  And that was agony.  And it’s left 
me with longstanding bladder issues. And it’s more that that I need to keep running to the 
toilet for, not my bowels.  So that’s where my distress is.” 
 
Towards the end of the focus group meeting, participants were asked to review the themes and sub-
themes derived from the secondary analysis of qualitative data previously described (Phase 1). They 
confirmed that these were either representative of their collective experiences or recognised them as 
likely to be distressing to people with IBD.      
Phase 3: Findings of Delphi survey 
Of the 63 health professionals contacted, 20 (32%) returned completed surveys, across five 
disciplines: 16 Specialist IBD nurses (80%), 1 gastroenterologist, 1 general practitioner, 1 psychiatrist 
and 1 psychologist (5% each). The specialist nurses were employed in acute hospitals, outpatients, 
district general hospitals and secondary care and had between under a year and 13 years’ (mean 
6.75) clinical experience. The remaining professionals had between two and 32 years’ experience 
(mean 16.75) in acute inpatient, specialist hospital and general practice settings, and academic 
research.   
 
Fifteen of the 51 items (29%), which achieved 100% agreement amongst experts, related to disease 
uncertainty, fatigue, diet, faecal incontinence, concerns about disease progression, uncomfortable 
social situations, feeling less attractive and emotions related to living with IBD such as anger, 
frustration, embarrassment, and feeling overwhelmed and burnt out.  A further 32 items (63%) 
achieved between 75-95% agreement, therefore 92% of all items received agreement of 75% or 
greater. The remaining four items (8%), which achieved agreement between 63-70%, focused on 
access to a regular doctor, beliefs around healthcare professionals’ knowledge of IBD, letting people 
down and feeling horrified about living with IBD. It was felt unlikely that an increased consensus would 
be achieved by undertaking further rounds and the single round Delphi survey was sufficient for this 
phase of the study. 
 
The health professionals  identified a further eight items (Table 3) that people with IBD within their 
clinical practice reported as distressing. Of these, two were similar to questions within the survey, but 
were specific to stoma formation and the others had not been identified from either earlier phase of 
this study and therefore warranted inclusion in a draft IBD-distress scale.  
 
Discussion 
This study is the first to identify disease-specific distress in IBD, as distinct from anxiety, depression 
and stress, supporting anecdotal evidence from clinical practice and previous studies7-10. It has been 
reported that patients may experience psychological distress when faced with an IBD diagnosis22, but 
an understanding of this concept from a patient’s perspective has not been developed. Five themes 
and several sub-themes have been identified that cause IBD-distress. Some of these are common to 
DSD, others are specific to IBD.  Notably, much of the distress was related to bowel symptoms and 
the associated taboo, which meant that people with IBD felt unable to talk to others about their 
condition and were fearful of others’ negative reactions. The burden of incontinence was recognised 
by Kemp and colleagues in a meta-synthesis of the health needs of people living with IBD23, but the 
taboo nature of faecal incontinence and distress caused by living with the unpredictability of the 
condition has not been captured within existing measures of health-related quality of life for IBD24-25. 
 
Our findings that people with IBD are distressed by interactions with physicians and that their 
symptoms have an impact on social functioning are supported by two large-scale surveys of people 
living with the condition across Europe26-27. Participants in this study perceive their concerns are not 
taken seriously by physicians similarly to one survey, which found that almost half of patients were not 
asked about the impact of symptoms on their quality of life26. Lack of understanding by others was 
also evident in this study, as were feelings of anger and frustration. This has been reported previously 
due to the invisibility of IBD and has been shown to adversely affect individuals living with the 
condition28. Distress extends to the potential need for surgery for IBD, in particular the potential for 
stoma formation. Fear of surgery has previously been reported to cause anxiety for people with IBD29, 
but it is unclear whether this would fulfil the criteria for the psychiatric diagnosis of anxiety and IBD-
distress may be a better conceptualization.  
 
Distress does overlap with depressive symptoms in diabetes, but depression did not explain all of the 
DSD experienced16-17 and a similar finding was evident in this study. Many people with IBD described 
feeling low in mood or sad, with some using the word “depressed” to describe the impact of the 
disease, but articulating a difference between distress and depression. However this was not 
measured specifically within this study and warrants further investigation. There is conflicting 
evidence to date supporting a link between anxiety and depression and IBD although previous studies 
have identified similar emotional themes to this study (feeling sad or frustrated)29 adding weight to the 
argument that IBD-distress may be a similar concept to DSD. For many people with IBD the severity 
of anxiety and depression do not reach the level for clinical diagnosis of these psychiatric disorders 
and attempts to treat people with psychological interventions for anxiety and depression have had 
mixed success29. This is not unexpected if the treatment is aimed at the wrong problem. Distress was 
evident in the majority, but not all, of the interviews analysed within the first phase of the study. Some 
people were talking about symptoms, for example, yet were not apparently distressed by them, while 
others were. This suggests that some people with IBD may be more prone to experience distress than 
others, some are more resilient and better able to cope with their disease and/or the distress 
associated with it, or that the individual was not distressed when the interview was conducted. This 
may be explained if some participants experienced better social support than others, which is known 
to influence adjustment to the disease29, or the participant may be less distressed if they were in 
remission at the time or had a longer disease duration27. 
 
Throughout the analysis care was taken to “unpick” distress caused by general life-events (e.g. 
finances and relationships) from disease-specific distress, but often people would be in financial 
distress because IBD impacted on their employment. This impact has been reported previously23,26-27, 
but normally related to health-related quality of life (QoL) rather than distress. Patient reported 
outcome measures that purport to measure QoL in IBD have been criticized for failing to measure key 
issues that were important to patients, such as disease control from the patient’s perspective30, and 
therefore have failed to gain traction in clinical practice or research. It may also be more appropriate 
to measure distress rather than QoL and that previously published tools have not gained widespread 
acceptance among patients or practitioners because they are measuring the wrong concept.   
 
When presented with a list of items causing distress to people with IBD, clinicians also reported 
recognising these within their own patient populations. The clinicians identified further items that had 
not been evident in the earlier patient-focused phases of the study. It has long been recognised that 
patient and clinician understanding of the impact of disease varies31, but equally data saturation 
within this study may not have been reached and had further participant interviews been conducted 
the items identified by clinicians may have emerged.  
Reflexivity and Rigour 
Improving rigour within thematic analysis requires the researcher to be transparent and provide a 
clear account of all methods used, to support interpretation with evidence from the data, to maximise 
reliability by using more than one coder and to compare findings to those of other studies as well as 
within the data set32 . Within this paper we have provided sufficient evidence for the reader to judge 
the interpretation of the data and detailed methods of data analysis based on a conceptual framework 
that incorporated both inductive reasoning and deductive using a priori codes21. The research 
analysis was an iterative and reflexive process and the use of a template provides a trail of evidence 
for the credibility of the study. Applicability of the codes, drawn from existing literature on a similar 
concept in another long-term condition, diabetes distress19-20, was assessed and verified by people 
living with IBD. 
Limitations 
This study initially relied on secondary analysis of previously collected interview data. These original 
studies did not seek to identify IBD-distress, therefore no specific questions about this were asked. 
Yet distress was evident in these data despite participants not being specifically questioned about 
this, which may be a strength of the study. The conceptual framework used to identify distress from 
interview data was based on an un-related long-term condition and therefore it was not unexpected 
that some of the items included in the framework specific to diabetes were irrelevant to people living 
with IBD. Using a conceptual framework from another condition may have led to some items specific 
to IBD-distress being missed from the thematic analysis. However the focus group were asked 
specifically to identify what was distressing about living with IBD and there was good agreement 
between data from the first two phases of the study. New themes and sub-themes identified in this 
study may not have captured IBD-specific distress in its entirety and further investigation is warranted. 
Participants in the focus group for this study were a self-selected population so may not be 
representative of all people with IBD, but this is similar in other studies that have sought to develop 
new instruments to measure aspects of living with IBD31. Nor did we confirm their diagnosis or 
measure disease severity or duration at the time of the original interviews or the focus group. Both 
disease severity and duration are known to be factors in poorer quality of life27, 33. 
Conclusion 
We have found evidence of disease-specific distress in IBD. Five distinct themes of emotional, 
healthcare-related, interpersonal/social, treatment-related and symptom-related distress have been 
identified and confirmed across all three phases of the study. Some items that cause distress may be 
common to all long-term conditions and there was variation in distress between individuals, but this 
study suggests that further investigation of IBD-distress is warranted.  We plan to use the findings 
from this study to develop a new scale to assess IBD-distress.   
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Table 1: Framework for analysis: distress in IBD 
Items from PAID18 Items from DDS1719 Concept 
 Emotional burden subscale  
Feeling that diabetes is taking up too much of your mental and 
physical energy every day 
Feeling that diabetes is taking up too much of my mental and 
physical energy every day 
Drain on energy 
Feeling scared when you think about living with diabetes 
Feeling depressed when you think about living with diabetes 
Feeling angry when you think about living with diabetes 
Feeling angry, scared and/or depressed when I think about living 
with diabetes 
Feeling angry, scared, 
depressed 
 Feeling that diabetes controls my life Disease controls my life 
Worrying about the future and the possibility of serious complications Feeling that I will end up with serious long-term complications, no 
matter what I do 
Worrying about 
complications 
Feeling overwhelmed by diabetes Feeling overwhelmed by the demands of living with diabetes Feel overwhelmed 
Feeling burned out by the constant effort needed to manage diabetes  Feel burnt out 
Not knowing if your mood or feelings are related to diabetes  Unclear about cause of 
mood 
Not accepting your diabetes  Not accepting diagnosis 
 Physician-related distress subscale  
Feeling unsatisfied with your diabetes physician Feeling that my Dr doesn’t know enough about diabetes and 
diabetes care 
Unsatisfied with health 
professionals 
Not having clear and concrete goals for your diabetes care Feeling that my Dr doesn’t give me clear enough directions on how 
to manage my diabetes 
Lack of clear goals 
 Feeling that my Dr doesn’t take my concerns seriously enough Concerns not taken seriously 
 Feeling that I don’t have a doctor who I can see regularly about my 
diabetes 
No regular doctor 
 Regimen distress subscale  
Worrying about low blood sugar reactions Feeling that I am not testing my blood sugars frequently enough  
Feeling guilty or anxious when you get off track with the diabetes 
management 
Feeling that I am often failing with my diabetes regimen Failing with regimen / feeling 
guilty 
 Not feeling confident in my day-to-day ability to manage diabetes Lack confidence 
Feeling constantly concerned about food and eating 
Feeling deprivation regarding food or meals 
Feeling that I am not sticking closely enough to a good meal plan Concern about diet 
Feeling discouraged with diabetes treatment plan Not feeling motivated to keep up my diabetes self-management Discouraged/not motivated 
Coping with complications of diabetes  Coping with complications 
 Interpersonal distress subscale  
Feeling that friends and family are not supportive of your diabetes 
management efforts 
Feeling that friends or family are not supportive enough of my self-
care efforts (e.g. planning activities that conflict with my schedule, 
encouraging me to eat the “wrong” foods) 
Friends and family not 
supportive 
 Feeling that friends or family don’t appreciate how difficult living 
with diabetes can be  
Lack of appreciation of 
difficulty 
 Feeling that friends or family don’t give me the emotional support 
that I would like 
Lack of emotional support 
Uncomfortable social situations related to your diabetes care  Uncomfortable social 
situations 
Feeling alone with your diabetes  Feeling alone 
  Any others 
 
  
Table 2: Themes identified causing distress in IBD identified from secondary analysis (Phase 1) 
Theme Sub-themes common to IBD and diabetes Sub-themes specific to IBD and not diabetes Sub-themes specific to diabetes and not IBD 
Emotional distress • Feeling negative emotions 
(angry, scared, depressed) 
• Feeling disease controls my life 
• Feeling overwhelmed 
• Feeling burnt out 
• Not accepting diagnosis 
• Feeling anxious 
• Feeling frustrated / fed-up / miserable / 
devastated / hopeless 
• Feeling embarrassed/ feeling disgust 
• Living with uncertainty 
• Change in self-image / self-esteem 
• worrying about complications 
•  unclear about cause of mood 
Healthcare related 
distress 
• Unsatisfied with health 
professionals 
• Concerns not taken seriously 
• No regular doctor 
• Not being believed • lack of clear goals 
Interpersonal / 
social distress 
• Lack of appreciation of difficulty 
from family and friends 
• Lack of emotional support from 
family and friends 
• Uncomfortable social situations 
• Feeling alone/isolated 
• Lack of support at work 
• Worry about reactions of others 
• Taboo/ Can’t talk about it 
• Not being believed 
• Worry about impact on family 
• Fear/guilt of passing IBD on to actual or 
future children 
• friends and family not supportive with 
treatment/self-management;  
Treatment related 
distress 
• Concern about diet • Coping with treatment and side-effects • failing with regimen 
• coping with complications 
• not motivated regarding self-
management 
• lacking confidence in disease 
management 
Symptom related 
distress 
 • Drain on energy 
• Fear of faecal incontinence 
• Coping with symptoms 
• Impact on cognition 
 
 
 
  
  
Table 3: New items added from clinician suggested 
additional areas of distress (Phase 3) 
Worrying important life events, such as a 
wedding/holiday etc., may be ruined by a flare up in 
my IBD 
Worrying about how I will cope financially if I am 
unable to work 
Worrying that my stress and/or anxiety about IBD 
makes my IBD worse 
Worrying I may have to use nappies because of my 
bowel accidents 
Feeling anxious about making the right treatment 
decision for me as new drugs may be licenced soon 
Feeling that having surgery or a stoma will alter my 
self-image and sexual function 
Worrying about needing to have surgery or a stoma 
Worrying that I won't understand or be able to act on 
the warning signs of a flare up in my IBD 
 
 
